Effective Caregiving for Neonatal Abstinence Syndrome: Testing an Instructional Mobile Technology Platform for High-Risk Pregnant Women

Running, not enrolling · Not applicable

Conditions studied: Neonatal Abstinence Syndrome, Opioid-use Disorder

In brief

Most newborns experiencing Neonatal Abstinence Syndrome (NAS) require non-pharmacologic care, which entails, most importantly, maternal involvement with her newborn. To facilitate positive maternal-newborn interactions, mothers need to learn effective caregiving NAS strategies while they are pregnant, yet, an enormous gap exists in the early education of mothers on the symptoms and progression of NAS, in part because no interventions exist to prepare future mothers for the challenges of caring for their newborns at risk for NAS. In this project, the investigators propose to adapt an existing mobile NAS tool for high-risk pregnant women and assess its usability, acceptability, and feasibility in a small randomized controlled analog trial.

Key facts

Study ID

NCT04783558

Run by

Washington State University

People needed

30

Starts

2024-07-15

Expected to finish

2026-09-30

Last updated by the study team

2026-02-05

Who can join

Age: 18 and older, up to 99. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Pregnant woman in the third trimester currently in OAT treatment for opioid use disorder
• 18 years of age or older
• Ability to speak and understand English.

You may not qualify if…

• Recurring (e.g. daily or almost daily) thoughts of harming themselves or others in the past 2 weeks.

Where it is running

• Washington State University — Spokane, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.